mdr case study
play

MDR Case Study Legal Action To Ensure Treatment of Tuberculosis - PowerPoint PPT Presentation

MDR Case Study Legal Action To Ensure Treatment of Tuberculosis Yuma Yuma Yuma Territorial Prison State Historic Park Yuma Yuma Yuma Case History 69 year old Native American male. Worked as a custodian Hx of DM Type 2 HTN


  1. MDR Case Study Legal Action To Ensure Treatment of Tuberculosis

  2. Yuma

  3. Yuma

  4. Yuma Territorial Prison State Historic Park

  5. Yuma

  6. Yuma

  7. Yuma

  8. Case History • 69 year old Native American male. • Worked as a custodian • Hx of DM Type 2 • HTN • Abnormal Heart Cath(showing multi vessel disease, in need of CABG)

  9. Case History • Patient underwent preoperative testing. • 2 days prior to surgery all testing was completed and showed the following: • CXR showed Bilateral upper and lower lobe atelectasis. • Upon abnormal results patient was sent for CT of Chest.

  10. Case History • CT of Chest revealed thick cavitary lesion in the left upper lobe measuring 5 cm, and a second thick cavitary lesion in the left lower lobe measuring 2 cm, 5 cm cavitary lesion in right hilar region with two other cavities in the right upper lobe measuring 1 cm.

  11. Case History • Cardiac surgery was delayed in the process to verify lung cavitations etiology. • Patient was admitted to local hospital by Cardiac surgeon for further testing. • Pulmonary consult was done. • With no hx of recent TB exposure or cough, a differential dx of Cancer was raised.

  12. Case History • Once evaluated by Pulmonologist, patient reported symptoms of: • Night sweats • Fevers • Weight loss of 40 lbs in the last 6 months

  13. Case History • Patient was moved to negative pressure room. • PPD was placed. • Bronchoscopy with transbronchial biopsy was scheduled.

  14. Case History • Results: • PPD 26 mm of induration • Pathology report findings: No malignancy cells identified. • AFB smear : (1+) • PCR: MTB complex with Rifampin resistance Phenotype detected

  15. Management • Patient was started on TB medications: Isoniazid, PZA, and Ethambutol. • Health Department was notified. • Health Department collaborated with ADHS. • Specimen was sent for molecular testing and secondary drug susceptibilities. • Heartland consult was done.

  16. Management • Contact investigation was started and 13 contacts identified. • All household contacts negative (6) • 2 contacts outside home had positive PPD’s and preventive tx was started. • Multiple people at pt’s work tested by employer with no new positive readings.

  17. Management • Patient was discharged home after two 2wks of treatment. • Rifampin was added to regimen. • Recommendations from Heartland received for new regimen that included IV infusions.

  18. Management • Challenges: • No Home Health Agency available to administer IV infusions • Difficulty obtaining second line drugs • No other facilities available • Collaborated with IHS for possible placement in IHS facility

  19. Management • While working through challenges, all TB medications were discontinued. • Only option left was local hospital. • 1 ½ month after TB dx patient was admitted to local hospital and started on Amikacin IV, Linezolid, Moxifloxacin, Ethionamide, and Ethambutol.

  20. Management • Patient remained compliant throughout TB treatment. • 3 months into TB treatment patient suffered heart attack while hospitalized. • Arrangements for CABG to be done while hospitalized were attempted but unsuccessful. • 3 consecutive Neg cx, DC, & readmission

  21. Case History • 26 year old Native American female Hx of DM, insulin dependent, IV drug use and multiple hospitalizations for DKA • Presents to Emergency Department with acute chest pain, cough, and generalized weakness for the past 3 days. • Lab work was done, CXR, a complete physical examination.

  22. Case History • Results showed: DKA, Sepsis, Bilateral Pneumonia, Hypokalemia and Dehydration • Patient was admitted to ICU. • Further testing was done.

  23. Case History • Patient had CT of Chest : showed prominent bilateral infiltrates and ill-defined nodular densities with a large thick walled irregular caveating area in the left upper lobe with possible bronchiectasis and a much smaller area of cavitation in the right lower lobe. • After CT findings patient was scheduled for Bronchoscopy.

  24. Case History • Patient underwent bronchoscopy and findings were as followed: • Pathology report: No atypical or malignant cells were identified. • AFB smear : RARE • PCR: MTB complex with Rifampin Resistance Phenotype detected.

  25. Management • Patient was moved to negative pressure room and patient was identified as a recent contact to family member with MDR Tuberculosis. • Health Department was notified. • Infectious Disease Doctor consulted with YPHSD and patient was immediately started on the 5 drug regimen previous MDR case was taking: Amikacin IV, Linezolid, Ethambutol, PZA, and Moxifloxacin.

  26. Management • YCPHSD notified ADHS of secondary MDR case and a consult to Heartland was initiated and BAL sample from hospital was sent to CDC for Molecular Testing and Secondary Drug Susceptibilities. • Drug resistance was confirmed and second contact investigation was done.

  27. Management • 53 Contacts were identified which included household members, health care workers and extended family. • 36 Contacts were evaluated: • 11 family members positive, 18 were lost to service and 27 were negative which were mostly healthcare workers.

  28. Management • ADHS then contacted the CDC team to assist with contact investigation. • CDC was able to investigate possible origin of transmission.

  29. Management • The team of physicians from the CDC worked with the community, local hospital and local health department and found previous MDR case had similar genotype from a group of MDR cases found in Mexico in the 70’s and confirmation was made that the patient acquired disease from the primary MDR case.

  30. Management • MDR case was hospitalized from 4/2/16-7/12/16. Once patient had 3 consecutive negative sputum cultures she was discharged and outpatient treatment was arranged. • Patient started outpatient treatment of daily oral medications and IV infusions three times per week. • Patient missed her first outpatient dose on 8/1/16 • Order to Cooperate was issued by 8/5/16

  31. Management • A total of 26 doses were missed in a 2 month period. • Patient’s weight dropped from 117lbs to 95lbs during the period she missed her treatment. • Patient’s Diabetes was uncontrolled again and started running blood sugars in the high 400’s to 500’s, with K+ levels of 2.1 • Patient tested positive for Methamphetamine use and plan for an Emergency Custody Order began. • Collaboration with ADHS, CDC, local hospital, County Attorney and Sheriff’s Office continued.

  32. Management • By 9/30/16 patient was re- evaluated and placed back into care and Emergency Custody Order was in place. • Patient was taken to Yuma County Detention Center and plan is for patient to complete TB treatment.

  33. Outcomes • Patient has not missed any more doses and was able to complete IV infusions successfully. • Patient has gained 52lbs • Diabetes is well managed. • No MDR transmission to the public.

  34. Outcomes • All positive contacts were started on preventive treatment and have successfully completed. • Contacts tolerated treatment with no problems.

  35. Outcomes • Ongoing collaboration between ADHS, CDC, local hospital, County Attorney, Sheriff Office, and Yuma County TB program enabled us to prevent the transmission of disease, improve the patient’s health, and kept our community healthy and safe.

  36. Questions?

Recommend


More recommend